covid-19 |
24 |
disease burden |
16 |
public health |
13 |
influenza virus |
12 |
death |
11 |
human influenza |
11 |
vaccination |
11 |
disparities |
10 |
intervention |
10 |
sars-cov-2 |
10 |
socioeconomic |
10 |
surveillance |
10 |
work from home |
10 |
hospitalization |
9 |
mass testing |
9 |
severity |
9 |
transmission dynamics |
9 |
immunity |
8 |
impact |
8 |
incidence rates |
8 |
influenza |
8 |
2009 h1n1 influenza |
7 |
adolescent |
7 |
antibody titer |
7 |
child |
7 |
incubation period |
7 |
influenza vaccine |
7 |
case clusters |
6 |
control |
6 |
epidemiological monitoring |
6 |
epidemiology |
6 |
generation time |
6 |
h7n9 subtype |
6 |
high-rise buildings |
6 |
humidity |
6 |
infectious disease outbreak |
6 |
influenza a |
6 |
influenza a virus |
6 |
interventions |
6 |
line list |
6 |
pandemic preparedness |
6 |
pandemic responses |
6 |
prediction |
6 |
reproduction number |
6 |
seasonality |
6 |
seriousness |
6 |
transmissibility |
6 |
controlled study |
5 |
coronavirus disease 2019 |
5 |
disease control |
5 |
disease severity |
5 |
disease transmission |
5 |
medical sciences |
5 |
epidemiologic methods |
4 |
excess mortality |
4 |
in-hospital mortality |
4 |
influenza‐like illness |
4 |
mortality |
4 |
out-of-hospital mortality |
4 |
systematic review |
4 |
systematic reviews |
4 |
age factors |
3 |
aircraft |
3 |
antimicrobial resistance |
3 |
asia-pacific |
3 |
coronavirus |
3 |
ebola virus |
3 |
hospitalisation |
3 |
influenza, human - epidemiology - prevention and control |
3 |
key words influenza |
3 |
methicillin resistance |
3 |
mrsa |
3 |
pandemics |
3 |
staphylococcus aureus |
3 |
travel |
3 |
2019 novel coronavirus disease |
2 |
breathing disorder |
2 |
care homes |
2 |
china |
2 |
classification |
2 |
communicable disease |
2 |
coughing |
2 |
disease surveillance |
2 |
education |
2 |
environmental protection |
2 |
epidemiological parameters |
2 |
hand washing |
2 |
human |
2 |
infection control |
2 |
influenza - mathematical models |
2 |
influenza - mathematical models. |
2 |
influenza a (h1n1) |
2 |
influenza viruses |
2 |
lockdown |
2 |
mathematical modeling |
2 |
nonhealthcare settings |
2 |
nonhuman |
2 |
nonpharmaceutical measures |
2 |
pandemic |
2 |
public health surveillance - mathematical models |
2 |
public health surveillance - mathematical models. |
2 |
schools |
2 |
social distancing |
2 |
transmission |
2 |
children |
1 |
hiv |
1 |
lopinavir/ritonavir |
1 |
virologic failure |
1 |